Cantargia AB | Key People and Executives

Gunnar Magnus Modee Persson
Chairman
Anders Martin-Löf
Director
Corinne Savill
Director
Patricia Delaite
Director
Karin Leandersson
Director
Thoas Michael Fioretos
Director
Claus Asbjørn Andersson
Director
Gunnar Magnus Modee Persson
Chairman
Göran Forsberg
Chief Executive Officer
Liselotte Larsson
Vice President-Operations
Bengt Jöndell
Chief Financial Officer
Lars Thorsson
Vice President-Clinical Development
Anders Martin-Löf
Director
Corinne Savill
Director
Patricia Delaite
Director
Karin Leandersson
Director
Thoas Michael Fioretos
Director
Claus Asbjørn Andersson
Director

About Cantargia AB

View Profile
Address
Medicon Village
Lund SN 223 81
Sweden
Employees -
Website http://www.cantargia.com
Updated 09/14/2018
Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. It focuses on the development of CAN04 for the treatment of non-small cell lung cancer and pancreatic cancer. The company was founded by Thoas Michael Fioretos, Kjell Torsten Sjostrom, and Marcus Jaras on October 26, 2009 and is headquartered in Lund, Sweden.